Treating rheumatoid arthritis with tofacitinib for 6 months is linked to an increase in lower limb muscle volume, especially in the thigh, and a rise in serum creatinine levels.
The deceleration in CKD prevalence growth after 2012, along with the declining incidence trends may reflect the impact of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback